Adenoviral Gene Transfer in Arteries of Hypercholesterolemic Nonhuman Primates
- 10 April 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (6) , 815-821
- https://doi.org/10.1089/hum.1998.9.6-815
Abstract
Arterial gene transfer with adenoviral vectors is a promising approach for the treatment and prevention of vascular disorders. However, in small animals such as rats and rabbits adenoviral vectors can have deleterious effects on the artery wall. The effects of adenovirus in primate arteries have not been studied. AdRSVnLacZ, a replication-defective adenoviral vector, was delivered to the left brachial arteries of six hypercholesterolemic cynomolgus monkeys; right brachial arteries received vehicle only. Serum was collected before gene transfer and at vessel harvest 9 or 10 days later. Recombinant gene expression was present in occasional endothelial cells of transduced arteries, and all animals generated neutralizing antibodies. In transduced arteries, immunostaining revealed a fourfold increase in intimal and medial macrophage accumulation (p < 0.05); intimal cellularity was also significantly increased (twofold; p < 0.05). T cell density and total cellular proliferation (determined by bromodeoxyuridine labeling) were unaffected. In hypercholesterolemic nonhuman primates, adenoviral vectors increase vessel wall inflammation and promote the progression of early atherosclerotic lesions. The long-term consequences of these observations remain unclear; however, a better understanding of host responses to specific vector systems appears necessary for the development of safe and effective approaches to human vascular gene therapy. Adenoviral gene transfer is a promising approach for treating vascular disorders, but the effects of adenovirus on primate arteries are unknown. A replication-defective adenoviral vector was delivered to the left brachial arteries of six hypercholesterolemic cynomolgus monkeys; right brachial arteries received vehicle alone. At vessel harvest 9 or 10 days later, recombinant gene expression was present in occasional endothelial cells, and neutralizing antibodies were generated in all animals. In transduced arteries, intimal cellularity and macrophage accumulation increased significantly; T cell density and cellular proliferation were unaffected. In nonhuman primates, adenoviral vectors cause vessel wall inflammation that may promote progression of atherosclerosis.Keywords
This publication has 35 references indexed in Scilit:
- Vasomotor Dysfunction Early after Exposure of Normal Rabbit Arteries to an Adenoviral VectorHuman Gene Therapy, 1997
- Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.Journal of Clinical Investigation, 1997
- Identification of a cis-Acting Sequence in the Human Plasminogen Activator Inhibitor Type-1 Gene That Mediates Transforming Growth Factor-β1 Responsiveness in Endothelium in VivoPublished by Elsevier ,1996
- Time Course of Cellular Proliferation, Intimal Hyperplasia, and Remodeling Following Angioplasty in Monkeys With Established AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia.Journal of Clinical Investigation, 1995
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- Intratracheal Gene Delivery with Adenoviral Vector Induces Elevated Systemic IgG and Mucosal IgA Antibodies to Adenovirus andβ-GalactosidaseHuman Gene Therapy, 1995
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993